Given significantly high tumour-to-blood ratio of [89Zr]Zr-Df-ATG-101 and [89Zr]Zr-Df-anti-PD-L1, especially on day 7, we believe that these agents have potential to diagnose PD-L1 expression in tumours and provide satisfactory imaging properties in patients. Here, CD274 is linked to neoplasm.